Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omega Therapeutics Inc (NQ: OMGA )

0.8450 +0.0550 (+6.96%)
Streaming Delayed Price Updated: 2:49 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omega Therapeutics Inc

< Previous 1 2 3 4 5 Next >
Top 4 Health Care Stocks That Are Preparing To Pump This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics' Cancer Program Shows Encouraging Anti Tumor Activity In Liver Cancer
Omega Therapeutics Inc (NASDAQ: OMGA) announced preliminary data from the initial two dose level cohorts (n=8) from Part 1 of its Phase 1/2 MYCHELANGELO I study of OTX-2002 in hepatocellular carcinoma... 
Via Benzinga
Analyst Ratings for Omega Therapeutics
Via Benzinga
Omega Therapeutics: Q1 Earnings Insights
Via Benzinga
Analyst Expectations for Omega Therapeutics's Future
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors! 
Via InvestorPlace
Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics Announces Updates to its Board of Directors
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During the Friday's sesion, 157 stocks hit new 52-week lows. 
Via Benzinga
Omega Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Omega Therapeutics Appoints Chris Schade to its Board of Directors
Accomplished Industry Veteran Brings Deep Strategic and Operational Expertise 
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Omega Therapeutics to Participate in Two Upcoming Investor Conferences
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics Presents New Preclinical Data Demonstrating the Potential of Omega Epigenomic Controllers™ to Synergize with Immunotherapies at the ASCO 2023 Annual Meeting
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Omega Therapeutics Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
From Omega Therapeutics
Via GlobeNewswire
Omega Therapeutics to Present New Preclinical Data at the American Society of Clinical Oncology 2023 Annual Meeting
From Omega Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Omega Therapeutics Announces Clinical Supply Agreement to Evaluate the Combination of OTX-2002 and Atezolizumab in Hepatocellular Carcinoma
From Omega Therapeutics
Via GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
Via Benzinga
Omega Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Omega Therapeutics
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.